Keros Therapeutics Inc (KROS)

Stock-Based Compensation

$22.87M

TTM · Period ending: · USD

KROS logo

KROS Stock-Based Compensation

Latest reported$22.87M
KROS TTM Stock-Based Comp ($59.00K → $22.87M)
High-resolution chart · PNG

KROS stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Keros Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
22,867,000
26,032,000
28,696,000
30,591,000
35,422,000
35,665,000
34,872,000
32,996,000
32,890,000
31,146,000
28,763,000
26,185,000
22,228,000
19,981,000
18,682,000
17,231,000
15,561,000
13,616,000
11,722,000
9,949,000
8,289,000
6,579,000
4,097,000
2,593,000
1,186,000
60,000
59,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.